121 related articles for article (PubMed ID: 9484799)
1. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression.
Sangrajrang S; Denoulet P; Laing NM; Tatoud R; Millot G; Calvo F; Tew KD; Fellous A
Biochem Pharmacol; 1998 Feb; 55(3):325-31. PubMed ID: 9484799
[TBL] [Abstract][Full Text] [Related]
2. Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells.
Sangrajrang S; Denoulet P; Millot G; Tatoud R; Podgorniak MP; Tew KD; Calvo F; Fellous A
Int J Cancer; 1998 Aug; 77(4):626-31. PubMed ID: 9679768
[TBL] [Abstract][Full Text] [Related]
3. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
Ranganathan S; Dexter DW; Benetatos CA; Hudes GR
Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684
[TBL] [Abstract][Full Text] [Related]
4. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR
Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701
[TBL] [Abstract][Full Text] [Related]
5. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
6. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Ranganathan S; McCauley RA; Dexter DW; Hudes GR
Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
[TBL] [Abstract][Full Text] [Related]
7. Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines.
Sangrajrang S; Zidane M; Berda P; Moré MT; Calvo F; Fellous A
Cancer Chemother Pharmacol; 2000; 45(2):120-6. PubMed ID: 10663626
[TBL] [Abstract][Full Text] [Related]
8. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
Speicher LA; Laing N; Barone LR; Robbins JD; Seamon KB; Tew KD
Mol Pharmacol; 1994 Nov; 46(5):866-72. PubMed ID: 7969073
[TBL] [Abstract][Full Text] [Related]
9. Estramustine depolymerizes microtubules by binding to tubulin.
Dahllöf B; Billström A; Cabral F; Hartley-Asp B
Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
[TBL] [Abstract][Full Text] [Related]
10. Estramustine resistance.
Sangrajrang S; Calvo F; Fellous A
Gen Pharmacol; 1999 Aug; 33(2):107-13. PubMed ID: 10461848
[TBL] [Abstract][Full Text] [Related]
11. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Mohan R; Panda D
Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
Panda D; Miller HP; Islam K; Wilson L
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
[TBL] [Abstract][Full Text] [Related]
14. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
[TBL] [Abstract][Full Text] [Related]
15. Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes.
Yoshida D; Cornell-Bell A; Piepmeier JM
Neurosurgery; 1994 May; 34(5):863-7; discussion 867-8. PubMed ID: 8052384
[TBL] [Abstract][Full Text] [Related]
16. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
Stearns ME; Tew KD
Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
[TBL] [Abstract][Full Text] [Related]
17. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
19. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Essand M; Nilsson S; Carlsson J
Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lipophilins as determinants of tumor cell response to estramustine.
Tucker JM; Lipatova Z; Beljanski V; Townsend DM; Tew KD
J Pharmacol Exp Ther; 2005 Dec; 315(3):1158-62. PubMed ID: 16120813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
